Apollo Hospitals Enterprise Limited (IN:APOLLOHOSP)
:APOLLOHOSP
Want to see IN:APOLLOHOSP full AI Analyst Report?
APOLLOHOSP Stock Chart & Stats
₹7081.40
-₹42.50(-0.59%)
At close: 4:00 PM EST
₹7081.40
-₹42.50(-0.59%)
Day’s Range― - ―
52-Week Range₹6,680.00 - ₹8,624.20
Previous CloseN/A
Volume234.52K
Average Volume (3M)4.82K
Market Cap
₹1.22T
Enterprise Value₹1.25T
Total Cash (Recent Filing)₹31.44B
Total Debt (Recent Filing)₹79.87B
Price to Earnings (P/E)62.9
Beta0.89
Next Earnings
Aug 07, 2026EPS Estimate
38.01Next Dividend Ex-DateN/A
Dividend Yield0.27%
Share Statistics
EPS (TTM)116.28
Shares Outstanding143,784,650
10 Day Avg. Volume6,428
30 Day Avg. Volume4,819
Financial Highlights & Ratios
PEG Ratio1.60
Price to Book (P/B)11.25
Price to Sales (P/S)4.23
P/FCF Ratio149.78
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
₹9,700.00Price Target Upside36.98% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
EPS Forecast (FY)169.25
Revenue Forecast (FY)₹299.09B
Bulls Say, Bears Say
Bulls Say
Integrated Business ModelA diversified healthcare ecosystem (hospitals, pharmacies, diagnostics, digital care) creates durable cross-referrals and multiple revenue streams. This integration reduces single-segment cyclicality, supports customer retention, and enables margin capture from vertically linked services over time.
Improving Return On EquitySustained ROE improvement indicates stronger profitability and capital efficiency. Higher ROE supports reinvestment in capacity and specialties, signals effective management allocation of capital, and underpins long-term ability to generate shareholder value from existing assets.
Revenue And Margin ExpansionA return to stronger top-line growth with concurrent operating and net margin expansion shows recovery in utilization, pricing power, or higher‑mix tertiary care. Durable revenue and margin gains improve cash generation capacity and support long-term funding of network expansion and quality investments.
Bears Say
Rising LeverageLeverage approaching parity with equity increases financial rigidity and interest burden. For a utilization-sensitive business, higher debt reduces flexibility to absorb occupancy shocks or aggressive capital spending, and raises refinancing and covenant risks over a 2–6 month horizon and beyond.
Weak Cash ConversionLow and volatile FCF relative to net income limits the firm's ability to self-fund expansion, reduce leverage, or return capital. Choppy cash generation increases reliance on external financing and reduces resilience to demand slowdowns, making strategic investments or deleveraging harder.
Margin Pressure And VolatilityDeclining gross margins and historical margin volatility point to cost pressures, mix shifts, or pricing constraints. Sustained margin erosion would compress operating leverage and ROE, forcing either cost restructuring or higher pricing to maintain profitability, both of which carry execution risk.
Apollo Hospitals Enterprise Limited News
APOLLOHOSP FAQ
What was Apollo Hospitals Enterprise Limited’s price range in the past 12 months?
Apollo Hospitals Enterprise Limited lowest stock price was ₹6680.00 and its highest was ₹8624.20 in the past 12 months.
What is Apollo Hospitals Enterprise Limited’s market cap?
Apollo Hospitals Enterprise Limited’s market cap is ₹1.22T.
When is Apollo Hospitals Enterprise Limited’s upcoming earnings report date?
Apollo Hospitals Enterprise Limited’s upcoming earnings report date is Aug 07, 2026 which is in 53 days.
How were Apollo Hospitals Enterprise Limited’s earnings last quarter?
Apollo Hospitals Enterprise Limited released its earnings results on May 20, 2026. The company reported ₹36.8 earnings per share for the quarter, beating the consensus estimate of ₹33.351 by ₹3.449.
Is Apollo Hospitals Enterprise Limited overvalued?
According to Wall Street analysts Apollo Hospitals Enterprise Limited’s price is currently Undervalued.
Does Apollo Hospitals Enterprise Limited pay dividends?
Apollo Hospitals Enterprise Limited pays a Semiannually dividend of ₹10 which represents an annual dividend yield of 0.27%. See more information on Apollo Hospitals Enterprise Limited dividends here
What is Apollo Hospitals Enterprise Limited’s EPS estimate?
Apollo Hospitals Enterprise Limited’s EPS estimate is 38.01.
How many shares outstanding does Apollo Hospitals Enterprise Limited have?
Apollo Hospitals Enterprise Limited has 143,784,650 shares outstanding.
What happened to Apollo Hospitals Enterprise Limited’s price movement after its last earnings report?
Apollo Hospitals Enterprise Limited reported an EPS of ₹36.8 in its last earnings report, beating expectations of ₹33.351. Following the earnings report the stock price went up 0.905%.
Which hedge fund is a major shareholder of Apollo Hospitals Enterprise Limited?
Currently, no hedge funds are holding shares in IN:APOLLOHOSP
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Apollo Hospitals Enterprise Limited
Apollo Hospitals Enterprise Limited, through its group entities, delivers a comprehensive range of medical services both within India and across international borders. Its medical infrastructure spans primary, secondary, and tertiary levels of care. Within its tertiary hospitals, advanced medical treatments are available, specializing in fields such as cardiology, cancer treatment (oncology), neurology, orthopedics, urgent care, robotic surgical procedures, and organ transplantation. Beyond direct patient care, the company extends its offerings to include project advisory services, health coverage solutions, the operation of medical educational institutions, an e-learning platform called Medvarsity, and research initiatives. Furthermore, its operations encompass retail pharmacies, foundational primary care clinics, maternity and specialized birthing centers, focused single-specialty clinics, general primary health centers, diagnostic lab networks, dental clinics, as well as daycare and in-home healthcare services. The company's extensive presence is marked by 9,911 hospital beds, 4,529 pharmacies, and 1,734 retail healthcare centers nationwide. This is complemented by its digital ventures: Apollo 24/7, a comprehensive omni-channel healthcare platform, and www.apollopharmacy, its online pharmaceutical retail outlet. Established in 1979, Apollo Hospitals Enterprise Limited maintains its corporate headquarters in Chennai, India.
APOLLOHOSP Stock 12 Month Forecast
Average Price Target
₹9,700.00
▲(36.98% Upside)
Technical Analysis
Fortis Healthcare Ltd.
―
Max Healthcare Institute Ltd
―
Global Health Limited
―
Metropolis Healthcare Ltd.
―
Narayana Hrudayalaya Ltd.
―